← Back to Bills
HR 2407118th CongressFailed / ExpiredHouse

Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act

Policy Area: Health
View on Congress.gov
Origin Chamber
House
Last Updated
May 27, 2025
Latest Action Date
Dec 17, 2024

Latest Action

Reported (Amended) by the Committee on Ways and Means. H. Rept. 118-893, Part I.

Official Summary

Official summary has not been imported yet.

GovScope Watchdog™

AI Government Intelligence™
Executive Summary

The Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act (H.R. 2407) is a health policy bill introduced in the 118th Congress. The bill aims to address Medicare coverage for multi-cancer early detection screening tests. Although the official summary and full bill text are not available, the bill has been reported (amended) by the House Committee on Ways and Means as of December 17, 2024. The bill is currently classified as failed or expired and falls under the health policy area.

Bottom Line

H.R. 2407 sought to expand Medicare coverage to include multi-cancer early detection screening tests but did not advance to become law during the 118th Congress.

Policy Risk Level
🟡 Medium
Neutral Risk Assessment
Key Points
  • The bill focuses on Medicare coverage for multi-cancer early detection screening tests.
  • It was reported with amendments by the House Committee on Ways and Means on December 17, 2024.
  • The bill ultimately failed or expired without becoming law in the 118th Congress.
Who Benefits?

['Medicare beneficiaries potentially eligible for multi-cancer early detection screening', 'Healthcare providers offering cancer screening services', 'Medical device and diagnostic test manufacturers specializing in cancer detection']

Potential Concerns

['Implementation challenges related to integrating new screening coverage into Medicare policies', 'Potential costs to the Medicare program and federal budget', 'Oversight and regulation of multi-cancer screening tests to ensure accuracy and efficacy', 'Lack of publicly available full bill text limits detailed policy analysis']

Political Context

The bill was introduced and considered during the 118th Congress and was referred to the House Committee on Ways and Means, which reported it with amendments. Despite this progress, the bill did not pass and is listed as failed or expired. The policy area is health, specifically Medicare coverage for cancer screening technologies.

Hidden Impact Review

Hidden impact flags detected: 2

GovScope reviewed 2 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.

2 Detected
Detected Flags
Indirect Effects

['Potential increase in early cancer detection rates among Medicare beneficiaries if screening tests are widely adopted.', 'Possible stimulation of innovation and market growth in multi-cancer screening technologies.', 'Increased demand on healthcare providers for administering and interpreting new screening tests.']

GovScope Watchdog Notes

The absence of an official bill summary and full text limits the ability to conduct a comprehensive analysis. Transparency would be improved by providing full legislative text and detailed summaries. Monitoring cost estimates and implementation plans would be important for oversight if similar legislation is reintroduced.

Passage Likelihood: LowConfidence: 75%Model: gpt-4.1-mini

GovScope Intelligence Roadmap

Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.

Enterprise Ready